胸腔注射尿激酶减少结核性渗出性胸膜炎胸膜粘连的效果观察

中国防痨杂志 ›› 2004, Vol. 26 ›› Issue (3): 158-160.

胸腔注射尿激酶减少结核性渗出性胸膜炎胸膜粘连的效果观察

黄子庆¹；黄洁²；

1.浙江省绍兴第二医院绍兴 312000；2.浙江省绍兴市第六人民医院绍兴 312000；

出版日期:2004-03-10 发布日期:2004-11-03

Study on treatment effect of intrapleural urokinase for tuberculous pleurisy

Huang Ziqing,Huang Jie.

Shaoxing NO.2 People’s Hospital of Zhejiang province,Shaoxing 312000

Online:2004-03-10 Published:2004-11-03

摘要/Abstract

摘要： 目的　观察胸腔注射尿激酶减少结核性渗出性胸膜炎胸膜粘连的效果。方法收治渗出性胸膜炎 120例。随机分成治疗组与对照组各 60例。治疗组第 1、2、3次抽液后注射尿激酶 10万IU+生理盐水 20ml,化疗方案等对照组注射生理盐水 20ml,化疗方案等其他治疗方法相同。结果胸液吸收时间治疗组 20.2±3.1d ,对照组 19.6±4.2d(P＞0.05 )。抽液总量 ,治疗组 3648±512ml,对照组 2934±478ml(P＜0.01)。抽液次数 ,治疗组 5.2±1.6次 ,对照组 4.8±1.6次 (P＞0.05 )。形成纤维分隔、多房积液 ,治疗组 2例 ,对照组 9例 (P＜0.01)。 2月后B超查胸膜厚度 ,治疗组 1.22±0.19mm ,对照组 1.48±0.32mm(P＜0.01)；肺功能FEV1% ,治疗组 89.2%±1.6% ,对照组 82.3%±2.1% (P＜0.01)。FVC%治疗组 94.3%±2.2% ,对照组 90.2%±2.4% (P＜0.01)。结论胸腔注射尿激酶能减少胸腔分隔、多房的形成。减轻胸膜增厚 ,改善肺功能。

关键词: 尿激酶, 结核,胸膜

Abstract: Objective To observe the curative effect intrapleural urokinase for tuberculous pleurisy.Methods One hardred and twenty patients with tuberculous pleurisy were randomly divided into 2 groups:treatment group and control group.The patients in the treatment group were injected with urokinase 100000IU intrapleurally each time after 1,2,3 thoracocentesis,and the patients in the control group were injected with 20ml physiological saline each time.The other therapies in both groups were the same.Results The duration of pleural effusion absorption in treatment group was (20.2±3.1) days,while it was (19.6±4.2) days in control group (P＞0.05).The mean volume of fluid drained in treatment group was (3648±512)ml,while it was (2934±478)ml in control group (P＜0.01).The mean number of fluid drained in treatment group was (5.2±1.6),while it was (4.8±1.6) in control group (P＞0.05).There were two patients with pleural adhesion and loculation in treatment group,but there were 9 cases in control group (P＜0.01).After two months,the mean thickness of pleura in treatment group was (1.22±0.19)mm by B ultrasonic wave test,but it was (1.48±0.32)mm in control group (P＜ 0.01).The lung function (FEV1%) examined was (89.2±1.6%) in treatment group,while it was (82.3±2.1%) in control group (P＜0.01).FVC% was (94.3±2.2%) in treatment group,while it was 90.2±2.4% (P＜0.01) in the control group.Conclusion Intrapleural urokinase can not only reduce pleural adhesion,loculation and thickening of the pleura but also improve lung function.

Key words: Urokinase, Tuberculosis pleurisy

黄子庆,黄洁,. 胸腔注射尿激酶减少结核性渗出性胸膜炎胸膜粘连的效果观察[J]. 中国防痨杂志, 2004, 26(3): 158-160.

Huang Ziqing,Huang Jie.. Study on treatment effect of intrapleural urokinase for tuberculous pleurisy[J]. Chinese Journal of Antituberculosis, 2004, 26(3): 158-160.

[1]	田瑶, 吴浩宇, 李然, 程漠鑫, 王晓丹, 陈禹. 胸腔内注射尿激酶预防儿童结核性渗出性胸膜炎胸膜肥厚和粘连的价值[J]. 中国防痨杂志, 2020, 42(10): 1036-1041.
[2]	陈玲,卢利红,孙君红. 尿激酶联合臭氧序贯冲洗辅助治疗结核性包裹性胸腔积液的临床效果[J]. 中国防痨杂志, 2018, 40(10): 1095-1098.
[3]	彭德虎林兆原石琳胡锦兴罗立全. B超检查对结核性胸膜炎患者胸腔尿激酶注入疗效评估的分析[J]. 中国防痨杂志, 2011, 33(6): 369-371.
[4]	张新高,刘冬媛,李素英,黎联,邓治平,李大才,赵烈炎,. 胸腔内注入尿激酶治疗有小房形成的胸腔积液[J]. 中国防痨杂志, 2001, 23(6): 376-378.
[5]	郝金柱, 曲海燕, 张春盛, 王晓萍, 綦继光, 孟凡敏, . 胸腔内注入尿激酶辅助治疗结核性纤维化性胸腔积液的临床观察[J]. 中国防痨杂志, 2000, 22(2): 83-85.